Drug Shortage Report for THYROGEN
| Report ID | 160682 |
| Drug Identification Number | 02246016 |
| Brand name | THYROGEN |
| Common or Proper name | THYROGEN |
| Company Name | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | THYROTROPIN ALFA |
| Strength(s) | 0.9MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 2 |
| ATC code | V04CJ |
| ATC description | OTHER DIAGNOSTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-16 |
| Estimated end date | 2022-06-06 |
| Actual end date | 2022-06-06 |
| Shortage status | Resolved |
| Updated date | 2022-06-09 |
| Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer service contact info: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-06-09 | French | Compare |
| v4 | 2022-06-09 | English | Compare |
| v3 | 2022-05-17 | English | Compare |
| v2 | 2022-05-16 | French | Compare |
| v1 | 2022-05-16 | English | Compare |
Showing 1 to 5 of 5